HES1 and cancer: Notch pathway negatively impacts the activity of the Wnt pathway in most cancers; Wnt can also impact the expression of DLL1, HES1 and NOTCH2 on the protein level, while β-catenin can also interact with NOTCH1 and reduce its ubiquitination [26].